Capital Point Ltd. (TASE:CPTP) sold 0.88% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) for $3.7 million on November 12, 2015. The sale is expected to leave to Capital Point earnings amounting to about $1 million. The Board and the ad-hoc commission has approved the transaction.

Capital Point Ltd. (TASE:CPTP) completed the sale of 0.88% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) on November 12, 2015.